Institute for Clinical Research, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, Selangor, Malaysia.
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
BMC Health Serv Res. 2024 Jan 5;24(1):34. doi: 10.1186/s12913-023-10397-8.
Translation into clinical practice for use of intravenous thrombolysis (IVT) for the management of ischemic stroke remains a challenge especially across low- and middle-income countries, with regional inconsistencies in its rate. This study aimed at identifying factors that influenced the provision of IVT and the variation in its rates in Malaysia.
A multiple case study underpinning the Tailored Implementation for Chronic Diseases framework was carried out in three public hospitals with differing rates of IVT using a multiple method design. Twenty-five in-depth interviews and 12 focus groups discussions were conducted among 89 healthcare providers, along with a survey on hospital resources and a medical records review to identify reasons for not receiving IVT. Qualitative data were analysed using reflective thematic method, before triangulated with quantitative findings.
Of five factors identified, three factors that distinctively influenced the variation of IVT across the hospitals were: 1) leadership through quality stroke champions, 2) team cohesiveness which entailed team dynamics and its degree of alignment and, 3) facilitative work process which included workflow simplification and familiarity with IVT. Two other factors that were consistently identified as barriers in these hospitals included patient factors which largely encompassed delayed presentation, and resource constraints. About 50.0 - 67.6% of ischemic stroke patients missed the opportunity to receive IVT due to delayed presentation.
In addition to the global effort to explore sustainable measures to improve patients' emergency response for stroke, attempts to improve the provision of IVT for stroke care should also consider the inclusion of interventions targeting on health systems perspectives such as promoting quality leadership, team cohesiveness and workflow optimisation.
将静脉溶栓 (IVT) 用于治疗缺血性脑卒中的方法转化为临床实践仍然是一项挑战,尤其是在中低收入国家,其使用率存在区域性差异。本研究旨在确定影响 IVT 提供情况及其在马来西亚的使用率差异的因素。
本研究采用基于慢性病个体化实施的多案例研究方法,在三家具有不同 IVT 使用率的公立医院中进行,使用多方法设计。对 89 名医疗保健提供者进行了 25 次深入访谈和 12 次焦点小组讨论,并进行了一项关于医院资源的调查和一份病历审查,以确定未接受 IVT 的原因。定性数据采用反思性主题分析方法进行分析,然后与定量结果进行三角分析。
在所确定的五个因素中,有三个因素明显影响了医院之间 IVT 的使用差异:1)通过质量卒中冠军的领导力;2)团队凝聚力,包括团队动态及其一致性程度;3)促进性工作流程,包括简化工作流程和熟悉 IVT。另外两个在这些医院中被一致认为是障碍的因素包括患者因素,主要包括延迟就诊,以及资源限制。约 50.0-67.6%的缺血性脑卒中患者因延迟就诊而错失接受 IVT 的机会。
除了在全球范围内努力探索可持续措施以改善患者对卒中的急救反应外,还应考虑将针对卫生系统视角的干预措施纳入提高卒中治疗中 IVT 提供情况的尝试中,如促进优质领导力、团队凝聚力和工作流程优化。